Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rae

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
American Journal of Human Genetics|April 17, 2002
A major predisposition locus for severe obesity, at 4p15-p14Steven Stone, Victor Abkevich, Steven C Hunt, et al.
BMC Cancer|December 17, 2009
Nuclear receptor coregulator SNP discovery and impact on breast cancer riskRyan J Hartmaier, Sandrine Tchatchou, Alexandra S Richter, et al.
British Journal of Cancer|October 3, 2013
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsN L Henry, H-P Chan, J Dantzer, et al.
Breast Cancer Research and Treatment|November 23, 2015
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancerBrian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.
Journal of Medicinal Chemistry|November 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, et al.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
Breast Cancer Research and Treatment|May 4, 2015
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialBrian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Science (New York, N.Y.)|January 16, 2010
The genetic map of Artemisia annua L. identifies loci affecting yield of the antimalarial drug artemisininIan A Graham, Katrin Besser, Susan Blumer, et al.
Cell Reports|February 10, 2022
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccinationPrasanti Kotagiri, Federica Mescia, William M Rae, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
American Journal of Human Genetics|April 17, 2002
A major predisposition locus for severe obesity, at 4p15-p14Steven Stone, Victor Abkevich, Steven C Hunt, et al.
BMC Cancer|December 17, 2009
Nuclear receptor coregulator SNP discovery and impact on breast cancer riskRyan J Hartmaier, Sandrine Tchatchou, Alexandra S Richter, et al.
British Journal of Cancer|October 3, 2013
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsN L Henry, H-P Chan, J Dantzer, et al.
Breast Cancer Research and Treatment|November 23, 2015
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancerBrian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.
Journal of Medicinal Chemistry|November 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, et al.
Breast Cancer Research and Treatment|November 15, 2011
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancerMichaela J Higgins, Tatiana M Prowell, Amanda L Blackford, et al.
Breast Cancer Research and Treatment|May 4, 2015
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trialBrian Leyland-Jones, Kathryn P Gray, Mark Abramovitz, et al.
Science (New York, N.Y.)|January 16, 2010
The genetic map of Artemisia annua L. identifies loci affecting yield of the antimalarial drug artemisininIan A Graham, Katrin Besser, Susan Blumer, et al.
Cell Reports|February 10, 2022
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccinationPrasanti Kotagiri, Federica Mescia, William M Rae, et al.
Pageof 30